Keyphrases
Continuous Glucose Monitoring
100%
Severe Hyperglycemia
100%
Hyperglycemia
57%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
42%
Glucose Level
28%
Point-of-care
28%
Dysglycemia
28%
Diabetes
14%
Corticosteroids
14%
Early Detection
14%
Improved Outcomes
14%
Physiological Stress
14%
Patient Demographics
14%
Glucose Measurement
14%
High-dose Chemotherapy
14%
Improved Detection
14%
History of Diabetes
14%
Glucose Monitoring
14%
Prolonged Hospitalization
14%
Total Parenteral nutrition
14%
Cell Treatment
14%
Adverse Clinical Outcomes
14%
Acceptable Zones
14%
Clarke Error Grid Analysis
14%
Chimeric Antigen Receptor T Cells (CAR-T)
14%
Mean Absolute Relative Difference
14%
Chimeric Antigen Receptor T-cell Therapy
14%
Point-of-care Glucose
14%
Medicine and Dentistry
Hyperglycemia
100%
Prospective Study
100%
Diabetes
33%
Autologous Stem Cell Transplantation
33%
Dysglycemia
33%
Patient Care
16%
Cytokine
16%
Patient Population
16%
Chimeric Antigen Receptor T-Cell Immunotherapy
16%
High Dose Chemotherapy
16%
Total Parenteral Nutrition
16%
Immunosuppressant
16%
Allogeneic Stem Cell Transplantation
16%
Physiological Stress
16%
Chimeric Antigen Receptor T-Cell
16%
Nursing and Health Professions
Hyperglycemia
100%
Continuous Glucose Monitoring
100%
Glucose Level
28%
Autologous Stem Cell Transplantation
28%
Dysglycemia
28%
Patient Care
14%
Patient Population
14%
Clinical Outcome
14%
Drug Megadose
14%
Immunosuppressive Agent
14%
Allogeneic Stem Cell Transplantation
14%
Total Parenteral Nutrition
14%
Chimeric Antigen Receptor T-Cell
14%
Chimeric Antigen Receptor T-Cell Immunotherapy
14%
Pharmacology, Toxicology and Pharmaceutical Science